Copyright
©The Author(s) 2021.
World J Gastroenterol. Jul 14, 2021; 27(26): 4236-4245
Published online Jul 14, 2021. doi: 10.3748/wjg.v27.i26.4236
Published online Jul 14, 2021. doi: 10.3748/wjg.v27.i26.4236
ALL patients | Propensity-matched patients | |||||
Characteristic | Drain (n = 76) | No drain (n = 49) | P value | Drain (n = 42) | No drain (n = 42) | P value |
Sex (M/F) | 54/22 | 33/16 | 0.660 | 31/11 | 29/13 | 0.629 |
Age | 57.58 ± 9.90 | 54.14 ± 12.63 | 0.092 | 57.4 ± 9.9 | 58.1 ± 10.8 | 0.739 |
BMI (kg/m2) | 24.71 ± 3.76 | 24.64 ± 3.72 | 0.915 | 24.3 ± 3.5 | 24.4 ± 2.7 | 0.879 |
ASA (1/2/3), n (%) | 0.562 | 0.565 | ||||
1 | 1 (1.3) | 0 (0.0) | 1 (2.4) | 0 (0.0) | ||
2 | 70 (92.1) | 44 (89.8) | 38 (90.5) | 38 (90.5) | ||
3 | 5 (6.6) | 5 (10.2) | 3 (7.1) | 4 (9.5) | ||
pT stage, n (%) | 0.605 | 0.805 | ||||
T1 | 39 (52.0) | 24 (49.0) | 20 (47.6) | 20 (47.6) | ||
T2 | 10 (13.3) | 11 (22.4) | 6 (14.3) | 10 (23.8) | ||
T3 | 9 (12) | 5 (10.2) | 6 (14.3) | 4 (9.5) | ||
T4a | 17 (22.7) | 9 (18.4) | 10 (23.8) | 8 (19) | ||
pN stage, n (%) | 0.888 | 0.760 | ||||
N0 | 34 (44.7) | 20 (40.8) | 16 (38.1) | 18 (42.9) | ||
N1 | 16 (21.1) | 12 (24.5) | 9 (21.4) | 11 (26.2) | ||
N2 | 14 (18.4) | 7 (14.3) | 9 (21.4) | 5 (11.9) | ||
N3 | 12 (15.8) | 10 (20.4) | 8 (19) | 8 (19) | ||
Previous abdominal operation, n (%) | 13 (17.1) | 13 (26.5) | 0.205 | 6 (14.3) | 10 (23.8) | 0.266 |
Neoadjuvant chemotherapy, n (%) | 5 (6.6) | 2 (4.1) | 0.704 | 4 (9.5) | 2 (4.8) | 0.676 |
Concurrent illness, n (%) | 34 (44.7) | 14 (28.6) | 0.070 | 18 (42.9) | 13 (31.0) | 0.258 |
- Citation: Liu H, Jin P, Quan X, Xie YB, Ma FH, Ma S, Li Y, Kang WZ, Tian YT. Feasibility of totally laparoscopic gastrectomy without prophylactic drains in gastric cancer patients. World J Gastroenterol 2021; 27(26): 4236-4245
- URL: https://www.wjgnet.com/1007-9327/full/v27/i26/4236.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i26.4236